Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?

被引：8
|
作者：
Hanna, G. G. [1 ]
Illidge, T. [2 ]
机构：
[1] Queens Univ Belfast, Ctr Canc Res & Cell Biol, 95 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland
[2] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Canc Sci, Manchester Canc Res Ctr,Christie Hosp, Manchester, Lancs, England
来源：
CLINICAL ONCOLOGY | 2016年 / 28卷 / 11期
关键词：
Checkpoint inhibition; immunotherapy; NSCLC; radiotherapy; IMMUNE-RELATED RESPONSE; TUMOR MICROENVIRONMENT; IONIZING-RADIATION; SOLID TUMORS; MELANOMA; MODULATION; MECHANISMS; IPILIMUMAB; RESISTANCE; DOCETAXEL;
D O I：
10.1016/j.clon.2016.07.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The goal of re-programming the host immune system to target malignancy with durable anti-tumour clinical responses has been speculated for decades. In the last decade such speculation has been transformed into reality with unprecedented and durable responses to immune checkpoint inhibitors seen in solid tumours. This mini-review considers the mechanism of action of immune modulating agents and the potential for combination with radiotherapy in the treatment of non-small cell lung cancer. (C) 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：726 / 731
页数：6
相关论文
共 50 条
  • [31] Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms
    Barnet, Megan B.
    Cooper, Wendy A.
    Boyer, Michael J.
    Kao, Steven
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (06)
  • [32] Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions
    Pathak, Ranjan
    Amini, Arya
    Hill, Addie
    Massarelli, Erminia
    Salgia, Ravi
    CANCERS, 2021, 13 (14)
  • [33] Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer Lacking Driver Mutations and Future Perspectives
    De Mello, Ramon Andrade Bezerra
    Voscaboinik, Rafael
    Luciano, Joao Vittor Pires
    Cremonese, Rafaela Vilela
    Amaral, Giovanna Araujo
    Castelo-Branco, Pedro
    Antoniou, Georgios
    CANCERS, 2022, 14 (01)
  • [34] Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC)-novel approaches and future outlook
    Horvath, Lena
    Thienpont, Bernard
    Zhao, Liyun
    Wolf, Dominik
    Pircher, Andreas
    MOLECULAR CANCER, 2020, 19 (01)
  • [35] Immunotherapy for Non-Small Cell Lung Cancer
    Yoon, Sung Ho
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (03) : 111 - 115
  • [36] Immunotherapy for non-small cell lung cancer
    Kagamu, Hiroshi
    RESPIRATORY INVESTIGATION, 2024, 62 (02) : 307 - 312
  • [37] Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer Database
    Bates, James E.
    Morris, Christopher G.
    Milano, Michael T.
    Yeung, Anamaria R.
    Hoppe, Bradford S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 138 : 75 - 79
  • [38] Interest of focal radiotherapy in case of oligoprogression under immunotherapy in the treatment of metastatic non-small cell lung cancer
    Gage, Anais
    Pereira, Bruno
    Belliere, Aurelie
    Janicot, Henri
    Jeannin, Gaelle
    Bourrachot, Clara
    Durand, Muriel
    Rolland-Debord, Camille
    Merle, Patrick
    BULLETIN DU CANCER, 2023, 110 (12) : 1234 - 1243
  • [39] Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer
    Chodavadia, Parth A.
    Jacobs, Corbin D.
    Wang, Frances
    Salama, Joseph K.
    Kelsey, Chris R.
    Clarke, Jeffrey M.
    Ready, Neal E.
    Torok, Jordan A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 261 - 273
  • [40] Synergistic effect of immunotherapy and radiotherapy in non-small cell lung cancer: current clinical trials and prospective challenges
    Yang, Hui
    Jin, Tao
    Li, Mengqian
    Xue, Jianxin
    Lu, Bo
    PRECISION CLINICAL MEDICINE, 2019, 2 (01) : 57 - 70
12345